Hantavirus cases spark surge in pharma, biotech stocks
CNBC • • health
Key Points:
- Pharmaceutical stocks, including Moderna, Inovio Pharmaceuticals, Novavax, and Emergent BioSolutions, saw gains following the World Health Organization's alert on a hantavirus outbreak linked to a Dutch-flagged cruise ship.
- Moderna announced ongoing preclinical research on hantaviruses in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases, though analysts caution that the outbreak is unlikely to generate significant revenue for the company.
- The hantavirus strain involved is the Andes virus, notable for human-to-human transmission, with eight cases and three deaths reported; however, the WHO has assessed the public health risk as low.
- The MV Hondius cruise ship has docked in Tenerife, Spain, and passengers and crew are disembarking under strict health protocols, with authorities managing testing, isolation, and repatriation efforts.
- U.S. President Donald Trump stated that the outbreak on the cruise ship is "very much under control," with a full report expected soon.